Evidence for a major role for glucagon in regulation of plasma glucose in conscious, nondiabetic, and alloxan-induced diabetic rabbits

Diabetes

Volumn 45, Issue 8, 1996, Pages 1076-1083

  Brand, Christian L ^a   Jørgensen, Peer N ^a   Svendsen, Ivan ^a   Holst, Jens J ^b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GLUCAGON; GLUCOSE; INSULIN;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; CONTROLLED STUDY; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029760864     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.8.1076     Document Type: Article

References (30)

1. Samols E: Glucagon and insulin secretion. In Handbook of Experimental Pharmacology, Vol. 66, No. 1: Glucagon. Lefèbrve PJ, Ed. Berlin, Springer-Verlag, 1983, p. 485-518
2. Goldberg DJ, Walesky M, Sherwin RS: Effects of somatostatin on the plasma amino acid response to ingested protein in man. Metabolism 28:866-872, 1979
3. Meneilly GS, Minaker KL, Elahi D, Rowe JW: Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia. Metabolism 37:252-256, 1988
4. 9] glucagon amide, a glucagon antagonist. Peptides 10:1171-1177, 1989
5. Flatt PR, Swanston-Flatt SK, Bailey CJ: Glucagon antiserum: a tool to investigate the role of circulating glucagon in obese-hyperglycaemic (ob/ob) mice (Abstract). Biochem Soc Trans 7:911-913, 1979
6. Almdal TP, Holst JJ, Heindorff H, Vilstrup H: Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes 41:12-16, 1992
7. Holst JJ, Galbo H, Richter EA: Neutralization of glucagon by antiserum as a tool in glucagon physiology. J Clin Invest 62:182-190, 1978
8. Tan K, Tsiolakis D, Marks V: Effect of glucagon antibodies on plasma glucose, insulin and somatostatin in the fasting and fed rat. Diabetologia 28:435-440, 1985
9. Barling P, Beloff-Chain A: Studies on the administration of glucagon and insulin antibodies to rats. Horm Metab Res 5:154-159, 1973
10. Grey N, McGuigan JE, Kipnis DM: Neutralization of endogenous glucagon by high titer glucagon antiserum. Endocrinology 86:1383-1388, 1970
11. Brand CL, Rolin B, Jørgensen PN, Svendsen I, Kristensen JS, Holst JJ: Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycemia in moderately streptozotocin-diabetic rats. Diabetologia 37:985-993, 1994
12. Brand CL, Jørgensen PN, Knikke U, Warberg J, Svendsen I, Kristensen JS, Holst JJ: The role of glucagon in the maintenance of euglycemia in fed and fasted rats. Am J Physiol 269:E469-E477, 1995
13. Albano JDM, Ekins RP, Maritz M, Turner RC: A sensitive, precise radioimmuno-assay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70:487-509, 1972
14. Heding LG: Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7:10-19, 1971
15. Ørskov C, Jeppesen J, Madsbad S, Holst JJ: Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87:415-423, 1991
16. Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartman B, Ørskov C: Proglucagon processing in porcine and human pancreas. J Biol Chem 269:18827-18833, 1994
17. Tai M: A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154, 1994
18. Holst JJ, Ørskov C: Glucagon and other proglucagon-derived peptides. In Gut Peptides: Biochemistry and Physiology. Walsh JH, Dockray GJ, Eds. New York, Raven, 1994, p. 305-340
19. Lok S, Kuijper JL, Jelinek LJ, Kramer JM, Whithmore TE, Sprecher CA, O'Hara PJ, Foster DC, Kindsvogel W: The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal location. Gene 140:203-209, 1994
20. Ørskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV: Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119:1467-1475, 1986
21. Richter EA, Galbo H, Holst JJ, Sonne B: Significance of glucagon for insulin secretion and hepatic glycogenolysis during exercise in rats. Horm Metab Res 13:323-326, 1981
22. Seino S, Sakurai H, Kuzuya H, Tsuda K, Tanigawa K, Takahashi K, Seino Y, Imura H: Effect of glucagon antiserum on somatostatin, glucagon and insulin release from the isolated perfused rat pancreas. Peptides 1:175-182, 1982
23. Cryer PE: Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol 264:E149-E155, 1993
24. Schwarts NS, Clutter WE, Shah SD, Cryer PE: Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777-781, 1987
25. Consoli A: Role of liver in pathophysiology of NIDDM. Diabetes Care 15:430-441, 1992
26. Smith D, Rossetti L, Ferrannini E, Johnson CM, Cobelli C, Toffolo G, Katz LD, DeFronzo RA: In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism 36:1167-1174, 1987
27. Cherrington AD, Liljenquist JE: Role of glucagon in regulating glucose production in vivo. In Current Endocrinology. Unger R, Orci L, Eds. New York, Elsevier/North-Holland, 1981, p. 221-253
28. Rosen SG, Clutter WE, Berk MA, Shah SD, Cryer PE: Epinephrine supports the postabsorbtive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man. J Clin Invest 73:405-411, 1984
29. Unger RH: Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27:1691-1709, 1978
30. Dinneen S, Alzaid A, Turk D, Rizza R: Failure of glucagon suppression contributes to postprandial hyperglycemia in IDDM. Diabetologia 38: 337-343, 1995